Physician profile
Brianna Pool
NPI 1689287518
$1,379.07
in general payments reported to CMS, 2019-2025
11 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $148 · 2023: $16.09 · 2024: $20.38 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.03 |
| Education | $354.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $293.34 | 2025 | |
| Janssen Biotech, INC. | $228.56 | 2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $216.19 | 2024-2025 | |
| Lilly USA, LLC | $164.16 | 2022-2023 | Mounjaro |
| Ucb, INC. | $147.19 | 2025 | Bimzelx |
| Sanofi-Aventis U.S. LLC | $94.99 | 2025 | |
| Genzyme Corporation | $93.98 | 2025 | |
| Novartis Pharmaceuticals Corporation | $56.32 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $37.92 | 2025 | Sotyktu |
| Leo Pharma INC. | $28.57 | 2025 | Anzupgo |
| Pfizer INC. | $17.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Pool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.